Header a MOSA O2

Header_Line_MOSA - www.mosao2.org - Medical Oxygen Society of the Amercias

HOME

Header_Line_MOSA - www.mosao2.org - Medical Oxygen Society of the Amercias

Header_Line_MOSA - www.mosao2.org - Medical Oxygen Society of the Amercias
Header_Line_MOSA - www.mosao2.org - Medical Oxygen Society of the Amercias
Header_Line_MOSA - www.mosao2.org - Medical Oxygen Society of the Amercias
Header_Line_MOSA - www.mosao2.org - Medical Oxygen Society of the Amercias Header_Line_MOSA - www.mosao2.org - Medical Oxygen Society of the Amercias

CONTACT

Header_Line_MOSA - www.mosao2.org - Medical Oxygen Society of the Amercias

3D Map of the Americas - MOSA - Medical Oxygen Society of the Americas

Header Logo - MOSA - Medical Oxygen Society of the Americas
Google Language Translator - MOSA - Medical Oxygen Society of the Americas - www.mosao2.org
   
   
HOME PAGE menu white arrow - MOSA - www.mosao2.org - Medical Oxygen Society of the Americas
NEWS / RESEARCH menu white arrow - MOSA - www.mosao2.org - Medical Oxygen Society of the Americas
   

bg grey mosao2

Spacer - MOSA - Medical Oxygen Society of the Americas - www.mosao2.org


MOSA - Article

Spacer - MOSA - Medical Oxygen Society of the Americas - www.mosao2.org


Oxygen Medicine Nutrition:

Mate Tea (Ilex paraguariensis) Improves Glycemic and Lipid

Profiles of Type 2 Diabetes and Pre-Diabetes Individuals:

a Pilot Study.

Logo - MOSA - Medical Oxygen Society of the Americas
Spacer - MOSA - Medical Oxygen Society of the Americas - www.mosao2.org

 

http://www.ncbi.nlm.nih.gov/pubmed/22081618

 

 

Mate Tea (Ilex paraguariensis) Improves Glycemic and Lipid Profiles of Type 2 Diabetes and Pre-Diabetes Individuals: a Pilot Study.

 

 

Klein GA, Stefanuto A, Boaventura BC, de Morais EC, Cavalcante Lda S, de Andrade F, Wazlawik E, Di Pietro PF, Maraschin M, da Silva EL.

 

Source

Department of Clinical Analysis, CCS, Federal University of Santa Catarina, Campus Universitario s/n, Trindade, Brazil.

 

 

________________________________________

 

 

Abstract

OBJECTIVES:

Yerba mate (Ilex paraguariensis) infusions have been shown to reduce plasma glucose in animals and serum lipids in humans. The aim of this study was to evaluate the effects of roasted mate tea consumption, with or without dietary counseling, on the glycemic and lipid profiles of individuals with type 2 diabetes mellitus (T2DM) or pre-diabetes.

 

 

________________________________________

 

 

METHODS:

Twenty-nine T2DM and 29 pre-diabetes subjects were divided into 3 groups: mate tea, dietary intervention, and mate tea and dietary intervention. Individuals drank 330 mL of roasted mate tea 3 times a day and/or received nutritional counseling over 60 days. Blood samples were collected and food intake was assessed at baseline and after 20, 40, and 60 days of treatments.

 

 

________________________________________

 

 

RESULTS:

Mate tea consumption decreased significantly the levels of fasting glucose (25.0 mg/dL), glycated hemoglobin A(1c) (HbA(1c)) (0.85%), and low-density lipoprotein cholesterol (LDL-c) (13.5 mg/dL) of T2DM subjects (p < 0.05); however, it did not change the intake of total energy, protein, carbohydrate, cholesterol, and fiber.

 

In pre-diabetes individuals, mate tea consumption combined with nutritional counseling diminished significantly the levels of LDL-c (11 mg/dL), non-high-density lipoprotein cholesterol (HDL-c) (21.5 mg/dL), and triglycerides (53.0 mg/dL) (p < 0.05).

 

Individuals of this group decreased significantly their consumption of total fat (14%), cholesterol (28%), and saturated (23.8%) and monounsaturated (28.0%) fatty acids, and increased their fiber intake by 35% (p < 0.05).

 

 

________________________________________

 

 

CONCLUSIONS:

Mate tea consumption improved the glycemic control and lipid profile of T2DM subjects, and mate tea consumption combined with nutritional intervention was highly effective in decreasing serum lipid parameters of pre-diabetes individuals, which may reduce their risk of developing coronary disease.

 

PMID: 22081618 [PubMed - indexed for MEDLINE]

 

________________________________________

 

 

http://www.ncbi.nlm.nih.gov/pubmed/22081618

 

   

 

 

Copyright @ 2011 www.mosa02.com. All Rights Reserved.


Disclaimer:

While every effort has been made to ensure that the information and data provided on this website are correct, no guarantee can be provided that
the information it contains is completely error-free. MOSA shall not be held liable for information and data that is not up-to-date, correct or complete.

MOSA reserves the right to edit, change or add to the information and data provided without prior notice. This website is produced and published
so that you can broaden your health education and options. Please consult your physician before considering any therapy.